JPS6230792A - 新規白金錯体 - Google Patents
新規白金錯体Info
- Publication number
- JPS6230792A JPS6230792A JP61094739A JP9473986A JPS6230792A JP S6230792 A JPS6230792 A JP S6230792A JP 61094739 A JP61094739 A JP 61094739A JP 9473986 A JP9473986 A JP 9473986A JP S6230792 A JPS6230792 A JP S6230792A
- Authority
- JP
- Japan
- Prior art keywords
- aminomethylazetidine
- platinum
- dichloro
- formula
- reacted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 229910052697 platinum Inorganic materials 0.000 title claims abstract description 15
- 239000000126 substance Substances 0.000 claims 2
- MRYNEEIGLSDRKH-UHFFFAOYSA-N azetidin-2-ylmethanamine Chemical compound NCC1CCN1 MRYNEEIGLSDRKH-UHFFFAOYSA-N 0.000 abstract description 13
- 230000000259 anti-tumor effect Effects 0.000 abstract description 9
- 150000001875 compounds Chemical class 0.000 abstract description 8
- -1 lithium aluminum hydride Chemical compound 0.000 abstract description 7
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 abstract description 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract description 5
- 231100000053 low toxicity Toxicity 0.000 abstract description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 abstract description 3
- 239000012280 lithium aluminium hydride Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 abstract description 2
- 230000003327 cancerostatic effect Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- QPINXQCQOKBINJ-UHFFFAOYSA-K potassium;platinum(2+);trichloride Chemical compound [Cl-].[Cl-].[Cl-].[K+].[Pt+2] QPINXQCQOKBINJ-UHFFFAOYSA-K 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229960004316 cisplatin Drugs 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 235000011164 potassium chloride Nutrition 0.000 description 3
- 239000001103 potassium chloride Substances 0.000 description 3
- 229910001961 silver nitrate Inorganic materials 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 125000003963 dichloro group Chemical group Cl* 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000003057 platinum Chemical class 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- WWYVZTLIFYLZFM-UHFFFAOYSA-N 1-methylazetidine Chemical compound CN1CCC1 WWYVZTLIFYLZFM-UHFFFAOYSA-N 0.000 description 1
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- RLHGHFMMOWLVJG-UHFFFAOYSA-N azetidin-1-ylmethanamine Chemical compound NCN1CCC1 RLHGHFMMOWLVJG-UHFFFAOYSA-N 0.000 description 1
- HONIICLYMWZJFZ-UHFFFAOYSA-N azetidine Chemical compound C1CNC1 HONIICLYMWZJFZ-UHFFFAOYSA-N 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- CCQPAEQGAVNNIA-UHFFFAOYSA-N cyclobutane-1,1-dicarboxylic acid Chemical compound OC(=O)C1(C(O)=O)CCC1 CCQPAEQGAVNNIA-UHFFFAOYSA-N 0.000 description 1
- UCRFYVVKDGVDJU-UHFFFAOYSA-L disodium;cyclobutane-1,1-dicarboxylate Chemical compound [Na+].[Na+].[O-]C(=O)C1(C([O-])=O)CCC1 UCRFYVVKDGVDJU-UHFFFAOYSA-L 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60-87616 | 1984-04-25 | ||
| JP60-87615 | 1985-01-22 | ||
| JP8761585 | 1985-04-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6230792A true JPS6230792A (ja) | 1987-02-09 |
| JPH0578560B2 JPH0578560B2 (enrdf_load_stackoverflow) | 1993-10-29 |
Family
ID=13919880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61094739A Granted JPS6230792A (ja) | 1985-04-25 | 1986-04-25 | 新規白金錯体 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6230792A (enrdf_load_stackoverflow) |
-
1986
- 1986-04-25 JP JP61094739A patent/JPS6230792A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0578560B2 (enrdf_load_stackoverflow) | 1993-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4115418A (en) | 1,2-diaminocyclohexane platinum (ii) complexes having antineoplastic activity | |
| EP0318464B1 (en) | Antitumor platinum complexes | |
| CA1164882A (en) | Compositions containing platinum | |
| EP0219936B1 (en) | Novel platinum complexes | |
| CA1134378A (en) | Cis-platinum(ii) amine lactate complexes | |
| US4234500A (en) | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes | |
| KR910009823B1 (ko) | 백금착물(白金錯物) | |
| KR0164460B1 (ko) | 고분자 백금 착화합물, 그의 제조방법 및 그를 유효성분으로 하는 항암제 | |
| EP0163316B1 (en) | Platinum-intercalative complexes for the treatment of cancer | |
| CA1332423C (en) | Platinum coordination compound | |
| CA1251203A (en) | Amino-anthracenediones-platinum complexes useful as anti-cancer compounds | |
| US4291027A (en) | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes | |
| KR100314720B1 (ko) | 포스파젠 삼합체에 도입된 백금 착물, 그의 제조방법 및 그를 유효성분으로 하는 항암제 | |
| US4175133A (en) | 1,2-Diaminocyclohexane platinum (II) complexes having antineoplastic activity against L1210 leukemia | |
| CA2046313C (en) | Platinum (ii) complex and agent for treating malignant tumor | |
| JPH02108693A (ja) | 白金（４）ジアミン錯体 | |
| JPS6230792A (ja) | 新規白金錯体 | |
| KR890004351B1 (ko) | 항 종양성 백금 착체의 제조방법 | |
| JPS61267595A (ja) | 新規白金錯体 | |
| EP0308910A2 (en) | Novel platinum complex | |
| JPH02108694A (ja) | 白金（２）ジアミン錯体 | |
| JPS6176497A (ja) | 白金錯体 | |
| JPH02212497A (ja) | 新規白金錯体及びその製法 | |
| JPS61148187A (ja) | 新規白金錯体 | |
| EP0261044A2 (en) | Novel platinum-riboflavin-complexes |